Cite
Brancaccio G, Salpini R, Piermatteo L, et al. An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms. 2021;9(4)doi: 10.3390/microorganisms9040752.
Brancaccio, G., Salpini, R., Piermatteo, L., Surdo, M., Fini, V., Colagrossi, L., Cantone, M., Battisti, A., Oda, Y., Di Carlo, D., Ceccherini-Silberstein, F., Perno, C. F., Gaeta, G. B., & Svicher, V. (2021). An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms, 9(4), . https://doi.org/10.3390/microorganisms9040752
Brancaccio, Giuseppina, et al. "An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression." Microorganisms vol. 9,4 (2021). doi: https://doi.org/10.3390/microorganisms9040752
Brancaccio G, Salpini R, Piermatteo L, Surdo M, Fini V, Colagrossi L, Cantone M, Battisti A, Oda Y, Di Carlo D, Ceccherini-Silberstein F, Perno CF, Gaeta GB, Svicher V. An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms. 2021 Apr 02;9(4). doi: 10.3390/microorganisms9040752. PMID: 33918474; PMCID: PMC8065957.
Copy
Download .nbib